GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated by Pfizer's ...
As an Elite ServiceNow partner, CRI Advantage enables companies to fully leverage the platform to modernize IT service delivery, enhance customer experiences, and scale secure operations. The post ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results